The CDC also mentioned respiratory syncytial virus (RSV), which is a virus that causes cold-like symptoms but also impacts breathing passages and the lungs. RSV has been trending upwards since ...

Viral pneumonia can sometimes stem from viruses that include the flu, common cold, COVID-19 and respiratory syncytial virus (RSV), according to Cleveland Clinic. This type of pneumonia typically ...

For the second time this summer, cases of RSV — or Respiratory Syncytial Virus — are unusually high in parts of the United States. While the illness is common and the typical cause of ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of the virus. A booster dose one year after the initial shot failed to do ...

A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The risk is three times higher within a year. RSV can lead to ...

The respiratory syncytial virus (RSV) is making its presence felt as the official season commenced in the second week of March, following a notable delay compared to historical patterns.

The virus causes an infection in the lungs and airways, with most people likely to experience mild to severe cold-like symptoms – 9266 cases of RSV have already been reported in Queensland this ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...